Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Showing results for

Oxford and Serum Institute of India sign IP license agreement to advance NipahB vaccine candidate

The University of Oxford and Serum Institute of India Pvt. Ltd. (SII), a Cyrus Poonawalla Group company and the world’s largest vaccine manufacturer, have signed an Intellectual Property license agreement to advance the development and manufacture of the ChAdOx1 NipahB vaccine candidate. Professor Brian Angus is Chief Investigator of the trial.

Oxford joins new West Africa consortium to accelerate climate and health solutions

Researchers from the University of Oxford have joined African universities and regional experts who are working with Wellcome to establish new science and policy consortiums that will address the escalating public health crisis driven by climate change - saving lives and livelihoods.

Strengthening Pharmacy resilience in public health crises in Nigeria

Dr Rachel Obonose Titus developed evidence-based Standard Operating Procedures (SOPs) to strengthen Nigerian community pharmacies during public health emergencies. Inspired by COVID-19 challenges, her work translates frontline experiences into practical policy tools. Through an AfOx Visiting Fellowship, she advanced evaluation and stakeholder engagement, aiming for national adoption and improved health system resilience.

My mission is to strengthen women’s futures in Congo and Africa through education and partnerships

Sarah Mugoli Balekage’s journey from the Democratic Republic of Congo to Oxford University is driven by faith and a commitment to empowering women through education. An Africa Oxford Initiative Scholar, she is pursuing African studies to advance social entrepreneurship and community advocacy, aiming to promote unity, development and opportunity across Africa.

New Study highlights demographic shift of visceral leishmaniasis to older patients and increased incidence of relapses in Brazil

A new study into visceral leishmaniasis (VL) in Brazil has created the most comprehensive picture of the disease in the country, and highlighted trends including more older patients being diagnosed with the disease and more patients presenting with relapses over time.

Identifying fake vaccines and insulin using hospital analysers

The Medicine Quality Research Group is part of the collaboration which has demonstrated that hospital analysers can be used to identify fake liquid medical products. This low-cost, accessible approach offers a promising tool for global health systems to protect patients, particularly in low-resource settings.

‘Peer power’ transforming HIV testing among fishing communities in Uganda

In Uganda’s fishing communities, Dr Joseph Matovu is leading a peer-led HIV self-testing project to overcome stigma and healthcare access barriers. With support from the Africa Oxford Initiative (AfOx), the PEST4MEN model empowers local leaders to distribute self-test kits, improving uptake, linkage to care, and community ownership of HIV prevention.

Professor Sir Nicholas White OBE KCMG FRS

The Centre for Tropical Medicine and Global Health, the University of Oxford and the Nuffield Department of Medicine greatly mourn the death of Professor Sir Nicholas White, a distinguished clinician and scientist who was internationally recognised as the leading figure in improving the treatment of malaria worldwide, and whose work has made a lasting contribution to global health research - saving millions of lives worldwide. Our thoughts are with his family at this time.

Deirdre Hollingsworth among the first Fellows of the Academy for the Mathematical Sciences

Professor Deirdre Hollingsworth is among twelve Oxford academics appointed to the Academy for the Mathematical Sciences’ inaugural cohort of Fellows, which will bring together the UK’s strongest mathematicians across academia, education, business, industry, and government to help solve some of the UK’s biggest challenges.

New interactive tool to assess devices for detecting substandard medicines

The Medicine Quality Research Group has launched DAFODIL, a new digital platform to help regulators assess portable devices for detecting substandard and falsified medicines. Poor-quality medicines, responsible for serious health risks, remain a major issue globally. DAFODIL compiles available scientific evidence to enable comparisons of medication screening devices, supporting informed decision-making. Developed with input from regulators and funded by the Gates Foundation, the tool aims to strengthen global medicine quality surveillance and response.

Oxford licenses Rift Valley fever vaccine candidate amid West Africa outbreak

The University of Oxford has licensed an investigational Rift Valley fever vaccine candidate to the Serum Institute of India (SII) as outbreaks of the disease continue in parts of West Africa. Professor George Warimwe leads the development of the ChAdOx1 RVF vaccine, now progressing from lab to field use. The initiative enables rapid vaccine production and testing, offering hope for controlling this neglected zoonotic disease.

GRAM to host 29th January webinar on AMR tools and resources

The GRAM Project invites health professionals, researchers, and policymakers to a webinar on 29 January: “AMR Tools and Resources: An Introduction for Health Professionals and Researchers.” The 90-minute session will showcase key tools including IHME’s MICROBE platform, WHO’s GLASS system, the AMR R package, and the GRAM–IDDO AMR Data Repository. These open-access resources support evidence-based action on antimicrobial resistance, particularly in low- and middle-income countries. Two identical sessions are offered to accommodate global participation.

Oxford-led researchers develop a low-cost rapid test to identify heat-damaged vaccines

Researchers from Medicine Quality Research Group, the University of Oxford and their collaborators have developed and evaluated a novel low-cost, rapid method to identify heat-exposed sucrose-containing vaccines without the need for sophisticated laboratory equipment.

Rapid, low-cost tests can help prevent child deaths from contaminated medicinal syrups

Researchers at the University of Oxford and their collaborators have demonstrated that simple, rapid, and inexpensive tests can detect deadly contaminants in medicinal syrups - contaminants that have tragically led to the deaths of hundreds of children worldwide.

Data platform will play a vital role in future VL research

A new publication authored by IDDO’s Visceral Leishmaniasis (VL) Scientific Advisory Committee sets out a research agenda for VL, and describes how IDDO established and developed a data platform that enables data reuse for crucial historical data.

‘Creeping catastrophe’: Climate change is driving global rise in infectious diseases, leading health experts warn

Infectious diseases such as malaria, dengue, and tuberculosis are considered to pose as great a challenge to global health as new or emerging pathogens, according to a major international study led by The Global Health Network at Oxford’s Nuffield Department of Medicine and commissioned by Wellcome.

Shaping Oxford’s Vision for Global Health in a Period of Turbulence

The first Oxford Global Health Summit united colleagues across the University to drive a bold, collaborative vision for global health.

Oxford Global Health welcomes Ghana’s High Commissioner for engagement on malaria and strengthening collaboration

Oxford Global Health welcomed Ghana’s High Commissioner and her delegation for a day of discussions on malaria elimination and future collaboration.

GRAM invites researchers to explore AMR data in repository

After gathering one of the largest collections of individual patient data on antimicrobial resistance (AMR) in the world, the Global Research on Antimicrobial Resistance (GRAM) Project is now inviting researchers to use this valuable resource in their own studies. The AMR data repository, hosted by the Infectious Diseases Data Observatory (IDDO), now covers nearly 70 countries and 250,000 patients, after launching last year to provide a secure, sustainable platform for global AMR data sharing. Holdings currently include 38 datasets from 24 different (GRAM) Project collaborators.

New study evaluates accuracy of rapid diagnostic tests for malaria

A new study, published in Malaria Journal, assessed the accuracy of rapid malaria tests (RDTs) across 12 sites in India and found that these tests were sub-optimal for detecting P. vivax malaria.

Load More